(Q77298809)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9737477%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

review article

1 reference

title

Antithrombotics in interventional cardiology: optimizing treatment and strategies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9737477%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

author name string

T A Ischinger

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9737477%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

publication date

1 September 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9737477%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Cardiology

4 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9737477%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

volume

82

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9737477%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

issue

5B

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9737477%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

page(s)

25L-28L

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9737477%20AND%20SRC:MED&resulttype=core&format=json

Angioplasty from bench to bedside to bench

4 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900109-X

Stent thrombosis. Closing in on the best preventive treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900109-X

A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900109-X

A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900109-X

Meeting highlights. The 69th Scientific Sessions of the American Heart Association in New Orleans, La, November 10-13, 1996

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900109-X

Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900109-X

Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900109-X

Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: a randomized study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900109-X

International workshop on antithrombotic therapy for acute coronary syndromes. May 9-10, 1996, Como, Italy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900109-X

Monitoring the effect of heparin by measurement of activated clotting time during and after percutaneous transluminal coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900109-X

Low-dose heparin for routine coronary angioplasty and stenting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900109-X

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900109-X

Low molecular weight heparins: a valuable tool in the treatment of acute coronary syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900109-X

A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900109-X

A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty. Helvetica Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900109-X

Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina. Hirulog Angioplasty Study Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900109-X

Safety observations from the pilot phase of the randomized r-Hirudin for Improvement of Thrombolysis (HIT-III) study. A study of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte (ALKK)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900109-X

A Comparison of Recombinant Hirudin with Heparin for the Treatment of Acute Coronary Syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900109-X

Hirudin in acute myocardial infarction. Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900109-X

Orally effective CVS-1123 prevents coronary artery thrombosis in the conscious dog.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900109-X

Platelet activation and coronary stent implantation. Effect of antithrombotic therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900109-X

Ticlopidine and aspirin pretreatment reduces coagulation and platelet activation during coronary dilation procedures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900109-X

A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900109-X

Intracoronary stent implantation without ultrasound guidance and with replacement of conventional anticoagulation by antiplatelet therapy. 30-day clinical outcome of the French Multicenter Registry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900109-X

Coronary stent placement in patients with acute myocardial infarction: comparison of clinical and angiographic outcome after randomization to antiplatelet or anticoagulant therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900109-X

Results of a consecutive series of patients receiving only antiplatelet therapy after optimized stent implantation. Comparison of aspirin alone versus combined ticlopidine and aspirin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900109-X

The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900109-X

Ticlopidine in unstable angina. A more expensive aspirin?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900109-X

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900109-X

Confusion in reperfusion. Problems in the clinical development of antithrombotic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900109-X

Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900109-X

EPILOG and CAPTURE trials halted because of positive interim results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900109-X

Glycoprotein IIb/IIIa receptor inhibitors: putting the EPIC, IMPACT II, RESTORE, and EPILOG trials into perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900109-X

Differential dose-response to oral xemilofiban after antecedent intravenous abciximab. Administration for complex coronary intervention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900109-X

Acute profound thrombocytopenia after C7E3 Fab (abciximab) therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900109-X

The Subcutaneous Heparin and Angioplasty Restenosis Prevention (SHARP) trial. Results of a multicenter randomized trial investigating the effects of high dose unfractionated heparin on angiographic restenosis and clinical outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900109-X

Low molecular weight heparin in prevention of restenosis after angioplasty. Results of Enoxaparin Restenosis (ERA) Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900109-X

Fish oils and low-molecular-weight heparin for the reduction of restenosis after percutaneous transluminal coronary angioplasty. The EMPAR Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900109-X

Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty. Results of a randomized, double-blind, unfractionated heparin and placebo-controlled, multicenter trial (REDUCE trial). Reduction of Restenosis After PTCA, E

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900109-X

High pressure assisted coronary stent implantation accomplished without intravascular ultrasound guidance and subsequent anticoagulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900109-X

PTCA: periprocedural platelet activation. Part II of the Duesseldorf PTCA platelet study (DPPS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900109-X

Association of heparin-resistant thrombin activity with acute ischemic complications of coronary interventions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900109-X

In vitro effects of the platelet glycoprotein IIb/IIIa receptor antagonist c7E3 Fab on the activated clotting time

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900109-X

Endogenous cell seeding. Remnant endothelium after stenting enhances vascular repair

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900109-X

10.1016/S0002-9149(98)00109-X

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9737477%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference